Dr. Rychik is director of the Fetal Heart Program and the Single Ventricle Survivorship Program at The Children’s Hospital of Philadelphia. He holds the Robert S. Harrington Endowed Chair of Pediatric Cardiology.
Under Dr. Rychik’s leadership, the mission of the Fetal Heart Program is to offer compassionate, state-of-the-art care to the fetus with heart disease and his or her family; offer a comprehensive, knowledge-based learning experience to expectant mothers carrying a fetus with heart disease and their families and advance our understanding and knowledge in the field of fetal heart science. The program is dedicated to early prenatal diagnosis through fetal echocardiography of congenital cardiac anomalies, allowing vigilant monitoring and preparation for postnatal treatment at CHOP’s renowned Cardiac Center.
Dr. Rychik has also been instrumental in contributing to the field’s knowledge about the cardiac aspects of other congenital conditions; for example, he developed the unique CHOP Scoring System for Twin-Twin Transfusion Syndrome, which allows more accurate staging of the disorder.
As leader of the Single Ventricle Survivorship Program, Dr. Rychik is focused on studying the long-term effects of current management strategies for single ventricle conditions, in the interest of improving therapies.
Dr. Rychik serves on the editorial board of numerous national and international journals including Fetal Diagnosis and Therapy, Progress in Pediatric Cardiology, Congenital Heart Disease, and the World Journal for Pediatric and Congenital Heart Surgery. He is a frequent lecturer and presenter at national and international pediatric cardiac conferences on complex cardiovascular disease in both fetal and pediatric patients.
Dr. Rychik has authored more than 250 peer reviewed research publications, books, reviews, chapters and abstracts on fetal and pediatric cardiac disorders and treatment. He recently completed a book and video image atlas entitled" Fetal Cardiovascular Imaging: A Disease Based Approach," which is expected to be the definitive text on the subject of imaging and management of fetal heart disease.
He brings over 10 years of experience to The Fetal Heart Program in the field of imaging and managing complex heart disease.« Back to Previous Page